OKG-0301
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OKG-0301, covering 2022-04-21 to 2022-04-21. Get the full timeline:
Most recent: Clinical Trial Update: OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis [Phase 2]